Market Closed -
BOERSE MUENCHEN
01:13:41 27/06/2024 am IST
|
5-day change
|
1st Jan Change
|
0.019
EUR
|
0.00%
|
|
-7.32%
|
-64.81%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2.587
|
5.304
|
17.44
|
10.95
|
3.333
|
8.962
|
Enterprise Value (EV)
1 |
2.622
|
4.496
|
17.05
|
10.28
|
3.081
|
8.823
|
P/E ratio
|
-2.64
x
|
-7.93
x
|
-21.1
x
|
-20.7
x
|
-6.52
x
|
-13.8
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
15.7
x
|
19.8
x
|
68.3
x
|
21
x
|
6.22
x
|
14.7
x
|
EV / Revenue
|
15.9
x
|
16.8
x
|
66.8
x
|
19.7
x
|
5.75
x
|
14.5
x
|
EV / EBITDA
|
-3.67
x
|
-9.42
x
|
-30
x
|
-28.8
x
|
-8.55
x
|
-30.3
x
|
EV / FCF
|
-6.14
x
|
-5.82
x
|
115
x
|
-59.4
x
|
-18.4
x
|
-133
x
|
FCF Yield
|
-16.3%
|
-17.2%
|
0.87%
|
-1.68%
|
-5.43%
|
-0.75%
|
Price to Book
|
3.39
x
|
3.33
x
|
16.3
x
|
9.2
x
|
4.71
x
|
94.6
x
|
Nbr of stocks (in thousands)
|
1,20,346
|
1,34,275
|
1,70,108
|
1,82,508
|
1,82,621
|
1,90,672
|
Reference price
2 |
0.0215
|
0.0395
|
0.1025
|
0.0600
|
0.0182
|
0.0470
|
Announcement Date
|
30/04/19
|
04/05/20
|
20/04/21
|
28/04/22
|
25/04/23
|
29/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
0.165
|
0.2679
|
0.2553
|
0.5211
|
0.5359
|
0.6094
|
EBITDA
1 |
-0.7149
|
-0.4771
|
-0.5692
|
-0.3569
|
-0.3603
|
-0.2909
|
EBIT
1 |
-0.7484
|
-0.5881
|
-0.6857
|
-0.4903
|
-0.5009
|
-0.4063
|
Operating Margin
|
-453.67%
|
-219.55%
|
-268.58%
|
-94.1%
|
-93.47%
|
-66.68%
|
Earnings before Tax (EBT)
1 |
-0.7641
|
-0.6171
|
-0.7175
|
-0.5011
|
-0.5116
|
-0.6238
|
Net income
1 |
-0.7641
|
-0.6387
|
-0.7175
|
-0.5011
|
-0.5116
|
-0.6238
|
Net margin
|
-463.16%
|
-238.42%
|
-281.04%
|
-96.16%
|
-95.47%
|
-102.37%
|
EPS
2 |
-0.008159
|
-0.004981
|
-0.004847
|
-0.002900
|
-0.002801
|
-0.003395
|
Free Cash Flow
1 |
-0.4273
|
-0.7729
|
0.1489
|
-0.173
|
-0.1673
|
-0.0664
|
FCF margin
|
-259.01%
|
-288.53%
|
58.31%
|
-33.21%
|
-31.23%
|
-10.89%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
30/04/19
|
04/05/20
|
20/04/21
|
28/04/22
|
25/04/23
|
29/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
0.03
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
0.81
|
0.39
|
0.67
|
0.25
|
0.14
|
Leverage (Debt/EBITDA)
|
-0.0477
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-0.43
|
-0.77
|
0.15
|
-0.17
|
-0.17
|
-0.07
|
ROE (net income / shareholders' equity)
|
-113%
|
-50.9%
|
-52.5%
|
-44.3%
|
-53.9%
|
-156%
|
ROA (Net income/ Total Assets)
|
-54.7%
|
-25.5%
|
-26%
|
-20.3%
|
-22%
|
-26.4%
|
Assets
1 |
1.397
|
2.508
|
2.764
|
2.466
|
2.33
|
2.366
|
Book Value Per Share
2 |
0.0100
|
0.0100
|
0.0100
|
0.0100
|
0
|
0
|
Cash Flow per Share
2 |
0
|
0.0100
|
0
|
0
|
0
|
0
|
Capex
|
-
|
0
|
-
|
0.01
|
0
|
-
|
Capex / Sales
|
-
|
1.52%
|
-
|
1.13%
|
0.28%
|
-
|
Announcement Date
|
30/04/19
|
04/05/20
|
20/04/21
|
28/04/22
|
25/04/23
|
29/04/24
|
|
1st Jan change
|
Capi.
|
---|
| +67.16% | 426.14Cr | | +6.56% | 271.18Cr | | -2.10% | 263.46Cr | | -53.68% | 171.66Cr | | -17.92% | 167.05Cr | | -20.18% | 144.66Cr | | +15.80% | 118.85Cr | | -47.67% | 101.08Cr | | +12.39% | 95Cr |
Medical & Diagnostic Laboratories
|